Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence.
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence – Drugs Related: RCT: Early treatment with fluvoxamine reduced the risk of emergency care and hospitalization among patients with COVID-19. [Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19. Opinion | Could this be our first […]
The post Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence. appeared first on Links Medicus.
Retrospective Cohort Study: Except for Rituximab, most immunosuppressive medicines were not associated with increased risk of mechanical ventilation or death in patients hospitalized with Covid-19.
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative – The Lancet Rheumatology Commentaries: What does endemic COVID-19 mean for the future of rituximab? – The Lancet Rheumatology Outcomes for hospitalized COVID-19 patients taking immunosuppressive medications similar to non-immunosuppressed patients, study finds – […]
The post Retrospective Cohort Study: Except for Rituximab, most immunosuppressive medicines were not associated with increased risk of mechanical ventilation or death in patients hospitalized with Covid-19. appeared first on Links Medicus.
The Omicron Variant Is a Mystery. Here’s How Science Will Solve It – “So far, panic about the new Covid variant has outpaced actual information. Here’s what scientists around the world are trying to uncover”.
The Omicron Variant Is a Mystery. Here’s How Science Will Solve It – Wired See also the latest articles on the subject: Where did ‘weird’ Omicron come from? – Science We can prevail over Omicron. We just need to use the tools we have – The Guardian How South African Researchers Identified the Omicron Variant […]
The post The Omicron Variant Is a Mystery. Here’s How Science Will Solve It – “So far, panic about the new Covid variant has outpaced actual information. Here’s what scientists around the world are trying to uncover”. appeared first on Links Medicus.
Another randomized trial showed convalescent plasma does not benefit patients hospitalized with Covid-19.
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial – JAMA Network Open Related: M-A: Convalescent plasma does not reduce mortality in COVID-19. RCT: Another study shows convalescent plasma does not improve outcomes in critically ill patients with Covid-19. RCT: Convalescent […]
The post Another randomized trial showed convalescent plasma does not benefit patients hospitalized with Covid-19. appeared first on Links Medicus.
Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic.
Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic – Critical Care
The post Complete countrywide mortality in COVID patients receiving ECMO in Germany throughout the first three waves of the pandemic. appeared first on Links Medicus.
FDA panel narrowly recommends authorization of first antiviral pill to treat COVID.
FDA panel narrowly recommends authorization of first antiviral pill to treat COVID – STAT See also: An FDA panel supports Merck COVID drug in mixed vote – NPR Related: [Press release – not published yet] Merck’s new Covid-19 pill Molnupiravir updated data shows reduced efficacy (30%) for preventing hospitalization and death compared to initial results […]
The post FDA panel narrowly recommends authorization of first antiviral pill to treat COVID. appeared first on Links Medicus.
Using wearable data, a real-time alerting system can be used for the early detection of Covid-19 and other stress events.
Real-time alerting system for COVID-19 and other stress events using wearable data – Nature Medicine Commentary: Scientists develop a smartwatch-based device for early detection of COVID-19 – News Medical Commentary on Twitter A study in @NatureMedicine shows that a smartwatch-based alerting system was able to detect pre-symptomatic and asymptomatic SARS-CoV-2 infection in a high […]
The post Using wearable data, a real-time alerting system can be used for the early detection of Covid-19 and other stress events. appeared first on Links Medicus.
M-A: Efficacy of non-invasive and invasive respiratory management strategies in adult patients with acute hypoxemic respiratory failure.
Efficacy of non-invasive and invasive respiratory management strategies in adult patients with acute hypoxaemic respiratory failure: a systematic review and network meta-analysis – Critical Care
The post M-A: Efficacy of non-invasive and invasive respiratory management strategies in adult patients with acute hypoxemic respiratory failure. appeared first on Links Medicus.
NICE Guideline | Tobacco: preventing uptake, promoting quitting, and treating dependence.
Tobacco: preventing uptake, promoting quitting and treating dependence – National Institute for Health and Care Excellence
The post NICE Guideline | Tobacco: preventing uptake, promoting quitting, and treating dependence. appeared first on Links Medicus.
Cohort study: Allergic conditions linked to lower COVID-19 infection risk.
News Release: Allergic conditions linked to lower COVID-19 infection risk – BMJ Original Study: Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) – Thorax
The post Cohort study: Allergic conditions linked to lower COVID-19 infection risk. appeared first on Links Medicus.